Exploratory Study of EBV-TCR-T Cell Injection for EBV DNAemia After Allogeneic Hematopoietic Stem Cell Transplantation

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Epstein-Barr Virus Infection · Post-Transplant Lymphoproliferative Disorder

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Chinese PLA General Hospital, Beijing, China
Contact: Study coordinator (Chinese PLA General Hospital) · 301irb@sina.com · 86-10-66937166

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Advanced Solid Tumors · Genital Neoplasm, Female · Urogenital Neoplasms

Abroad (travel likely)RecruitingPHASE1, PHASE2

Loma Linda, United States · Sacramento, United States

3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer

Brain and Central Nervous System Tumors · Chronic Myeloproliferative Disorders · Leukemia

Abroad (travel likely)Recruiting

Detroit, United States

Evaluation of CMV/EBV-CMI in Haploid HSCT

Hematopoietic Stem Cell Transplantation · Cytomegalovirus Infections · Epstein-Barr Virus Infections

Abroad (travel likely)Recruiting

Suzhou, China

Evaluation of the Efficacy of a Treatment by One Single Dose of Rituximab (375mg/m2 ) in the Prevention of the Epstein Barr Virus (EBV) Primary Infection and Post-transplant Lymphoproliferative Disorder in Adult EBV Seronegative Patients Who Received an EBV Seropositive Kidney Allograft

Epstein-Barr Virus Infections

Abroad (travel likely)RecruitingPHASE4

Strasbourg, France